These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18190943)

  • 41. Membrane interaction of Pasteurella multocida toxin involves sphingomyelin.
    Brothers MC; Ho M; Maharjan R; Clemons NC; Bannai Y; Waites MA; Faulkner MJ; Kuhlenschmidt TB; Kuhlenschmidt MS; Blanke SR; Rienstra CM; Wilson BA
    FEBS J; 2011 Dec; 278(23):4633-48. PubMed ID: 21951695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pasteurella multocida toxin activates various heterotrimeric G proteins by deamidation.
    Orth JH; Aktories K
    Toxins (Basel); 2010 Feb; 2(2):205-14. PubMed ID: 22069582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrastructural localization of the Pasteurella multocida toxin in a toxin-producing strain.
    iDali C; Foged NT; Frandsen PL; Nielsen MH; Elling F
    J Gen Microbiol; 1991 May; 137(5):1067-71. PubMed ID: 1865180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization of functional domains of the mitogenic toxin of Pasteurella multocida.
    Pullinger GD; Sowdhamini R; Lax AJ
    Infect Immun; 2001 Dec; 69(12):7839-50. PubMed ID: 11705966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin.
    Babb RC; Homer KA; Robbins J; Lax AJ
    PLoS One; 2012; 7(11):e47188. PubMed ID: 23144805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits.
    Suckow MA; Bowersock TL; Nielsen K; Chrisp CE; Frandsen PL; Janovitz EB
    Lab Anim Sci; 1995 Oct; 45(5):526-32. PubMed ID: 8569151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin.
    Orth JH; Blöcker D; Aktories K
    Biochemistry; 2003 May; 42(17):4971-7. PubMed ID: 12718539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of the Pasteurella multocida toxin translocation domain.
    Baldwin MR; Lakey JH; Lax AJ
    Mol Microbiol; 2004 Oct; 54(1):239-50. PubMed ID: 15458419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutation of a putative ADP-ribosylation motif in the Pasteurella multocida toxin does not affect mitogenic activity.
    Ward PN; Higgins TE; Murphy AC; Mullan PB; Rozengurt E; Lax AJ
    FEBS Lett; 1994 Mar; 342(1):81-4. PubMed ID: 8143855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological roles of Pasteurella multocida toxin (PMT) using a PMT mutant strain.
    Kim TJ; Toan NT; Jang EJ; Jung BG; Lee JI; Lee BJ
    J Microbiol; 2007 Aug; 45(4):364-6. PubMed ID: 17846592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Pasteurella multocida toxin on bone resorption in vitro.
    Felix R; Fleisch H; Frandsen PL
    Infect Immun; 1992 Dec; 60(12):4984-8. PubMed ID: 1452328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a robust GABA(B) calcium signaling cell line using beta-lactamase technology and sorting.
    Cui M; Chung FZ; Donahue CJ
    Cytometry A; 2008 Aug; 73(8):761-6. PubMed ID: 18612970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection by in-situ hybridization of Pasteurella multocida toxin (toxA) gene in the lungs of naturally infected pigs.
    Ahn KK; Lee YH; Ha Y; Kim D; Chae S; Kim CH; Lee JH; Kim SH; Chae C
    J Comp Pathol; 2008 Jul; 139(1):51-3. PubMed ID: 18495148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. G-Alpha Subunit Abundance and Activity Differentially Regulate β-Catenin Signaling.
    Banu A; Liu KJ; Lax AJ; Grigoriadis AE
    Mol Cell Biol; 2019 Mar; 39(5):. PubMed ID: 30559307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
    Kim TJ; Lee JI; Lee BJ
    J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The membrane localization domains of two distinct bacterial toxins form a 4-helix-bundle in solution.
    Hisao GS; Brothers MC; Ho M; Wilson BA; Rienstra CM
    Protein Sci; 2017 Mar; 26(3):497-504. PubMed ID: 27977897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Pasteurella multocida toxin with vimentin.
    Shime H; Ohnishi T; Nagao K; Oka K; Takao T; Horiguchi Y
    Infect Immun; 2002 Nov; 70(11):6460-3. PubMed ID: 12379728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An improved beta-lactamase reporter assay: multiplexing with a cytotoxicity readout for enhanced accuracy of hit identification.
    Hallis TM; Kopp AL; Gibson J; Lebakken CS; Hancock M; Van Den Heuvel-Kramer K; Turek-Etienne T
    J Biomol Screen; 2007 Aug; 12(5):635-44. PubMed ID: 17517902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase.
    Essler M; Hermann K; Amano M; Kaibuchi K; Heesemann J; Weber PC; Aepfelbacher M
    J Immunol; 1998 Nov; 161(10):5640-6. PubMed ID: 9820544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Pasteurella multocida toxin on physeal growth in young pigs.
    Ackermann MR; Register KB; Stabel JR; Gwaltney SM; Howe TS; Rimler RB
    Am J Vet Res; 1996 Jun; 57(6):848-52. PubMed ID: 8725812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.